Clinicopathological significance of RASSF1A reduced expression and hypermethylation in hepatocellular carcinoma - Wikidata - awgldk - TriplyDB

Clinicopathological significance of RASSF1A reduced expression and hypermethylation in hepatocellular carcinoma

Clinicopathological significance of RASSF1A reduced expression and hypermethylation in hepatocellular carcinoma

http://www.wikidata.org/entity/Q33718940

about

DNA methylation: potential biomarker in Hepatocellular Carcinoma.Synergistic effect of MiR-146a mimic and cetuximab on hepatocellular carcinoma cells.Inhibition of DNA methyltransferase activity and expression by treatment with the pan-deacetylase inhibitor panobinostat in hepatocellular carcinoma cell lines.Increased miR-221 expression in hepatocellular carcinoma tissues and its role in enhancing cell growth and inhibiting apoptosis in vitro.Decreased expression and clinical significance of miR-148a in hepatocellular carcinoma tissues.Underexpression of miR-34a in hepatocellular carcinoma and its contribution towards enhancement of proliferating inhibitory effects of agents targeting c-MET Differential methylation of the promoter and first exon of the RASSF1A gene in hepatocarcinogenesis.DNA methyltransferase 3b silencing affects locus-specific DNA methylation and inhibits proliferation, migration and invasion in human hepatocellular carcinoma SMMC-7721 and BEL-7402 cells.DNA markers in molecular diagnostics for hepatocellular carcinoma.MiR-146a rs2910164 polymorphism is associated with hepatocellular carcinoma: a meta-analysis.RASSF1 tumor suppressor gene in pancreatic ductal adenocarcinoma: correlation of expression, chromosomal status and epigenetic changes.RETRACTED: Decrease expression and clinicopathological significance of miR-148a with poor survival in hepatocellular carcinoma tissues Combination of serum RASSF1A methylation and AFP is a promising non-invasive biomarker for HCC patient with chronic HBV infection The Association of Ala133Ser Polymorphism and Methylation in Ras Association Domain Family 1A Gene With Unfavorable Prognosis of Hepatocellular Carcinoma.Asialoglycoprotein receptor-magnetic dual targeting nanoparticles for delivery of RASSF1A to hepatocellular carcinoma.Molecular alterations in the carcinogenesis and progression of hepatocellular carcinoma: Tumor factors and background liver factors.Expression and clinicopathological significance of miR-146a in hepatocellular carcinoma tissues.Hepatoepigenetic Alterations in Viral and Nonviral-Induced Hepatocellular Carcinoma.A 2015 survey of established or potential epigenetic biomarkers for the accurate detection of human cancers.Epigenetic mechanisms regulating the development of hepatocellular carcinoma and their promise for therapeutics.Methylation profiling of serum DNA from hepatocellular carcinoma patients using an Infinium Human Methylation 450 BeadChip."Testing your methyl": DNA methylation profiling of serum DNA of HCC patients.Pathogenetic and Prognostic Significance of Inactivation of RASSF Proteins in Human Hepatocellular Carcinoma.β-catenin interaction with NHERF1 and RASSF1A methylation in metastatic colorectal cancer patients

P2860

Q33617129-0C4FFC28-E46E-43C3-8AC6-BD868EAFBDE6 Q33660974-C040D9B5-F157-46A5-BFDC-BB794282CA60 Q34401887-5A085A01-275D-47B8-B3AA-197F173ABABF Q34548464-533C1F9C-0909-4D60-9CBD-75AFAE45796A Q34645417-4DC5AD24-77D9-4A95-B1FE-1784EDDBEC1A Q34674537-41A21585-BA0F-4688-82BE-F05464FEC2B2 Q35589600-6A3CC45A-3968-4187-AA96-25CBFC90EC49 Q35758190-1D83F6F9-1342-4215-B1DF-823AFFA44BB0 Q35781255-A2AC621B-7034-41A1-AACE-113AC5CCFA33 Q35858379-94325C1E-9C68-4178-92CD-B80A6570CF22 Q35891000-10261FFE-4F81-47CF-A4FA-D15DB4A873C0 Q35926654-47B2C6F9-AB7F-4E6E-9101-27968B87E76F Q35985943-F95A85AE-5BAE-488E-8DA1-F6CA8FA40E95 Q36279450-C075EABC-8DE3-4FA6-80F5-2C2B8BD1A9A9 Q36621264-00B9DD16-C239-464A-B056-F24860DFEAC6 Q37407115-5708F70A-F3EC-4A3B-993E-D0D9A0DF1470 Q37564156-2B89520F-8A26-4FB7-BCC7-B56B2AA68913 Q37571496-EFD54DDD-AA7D-468C-88AF-294F5668C13E Q38777365-D4074742-D051-4ECC-AA68-7610EB05C731 Q38857804-F81A7582-B48F-46CA-8076-FC04DC7573DE Q40706926-F536CDBC-5953-4567-A9D9-510032DB8439 Q40707010-086F8213-87A4-4CBD-9A27-E665F4C4C9E7 Q42040454-AFB18DF6-E3F3-4D15-A6B4-B96BBC5E4101 Q42315542-FB45D7BD-399E-4CC9-B2E7-A1771949137E

P2860

Clinicopathological significance of RASSF1A reduced expression and hypermethylation in hepatocellular carcinoma

http://www.wikidata.org/entity/Q33718940

description

2010 nî lūn-bûn

@nan

2010 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Clinicopathological significan ...... on in hepatocellular carcinoma

@ast

Clinicopathological significan ...... on in hepatocellular carcinoma

@en

type

label

Clinicopathological significan ...... on in hepatocellular carcinoma

@ast

Clinicopathological significan ...... on in hepatocellular carcinoma

@en

prefLabel

Clinicopathological significan ...... on in hepatocellular carcinoma

@ast

Clinicopathological significan ...... on in hepatocellular carcinoma

@en

P1433

Q33718940-B139AC5D-9883-473A-94E2-ECCCF3ECDC12

P1476

Q33718940-DCE2BBB2-4673-4EC4-B777-0C861E6B414D

P2093

Q33718940-18AD6EA0-C7F3-4BE0-B0EF-5E4ABEAE0371

Q33718940-375ED17B-5C26-466A-853A-1A781E66DBCC

Q33718940-72F7EB6E-9F48-4EF3-86A0-2DD6D3910F36

Q33718940-FA337B70-345F-4CC8-BAB9-61A527670A91

P2860

Q33718940-10017070-CE17-45D9-83DD-D9A2ADAAF359

Q33718940-111A6348-4142-47C6-B509-2567EAD98C23

Q33718940-13D76E60-AE5E-43A2-AAFC-A9B1B9787755

Q33718940-232D7283-E500-4B5B-8954-949841ED9241

Q33718940-2A1444D2-C346-4EB0-A666-680657AF6933

Q33718940-2C11BE2B-DF4C-4FD8-80F2-688922D3ABA1

Q33718940-2CAE2B49-B758-4BFC-AB27-9F735FCACF86

Q33718940-40A7AC01-6CE2-4CB9-A15D-840381D5ABCD

Q33718940-41FBF1FA-DDE8-447C-A4E1-1A0C2ED0E3D3

Q33718940-50554CB5-B5DD-4A5D-B58C-D4FD3506ADF8

P2888

Q33718940-632600F5-1E9C-4DD7-9AB1-08B36D917AE6

P304

Q33718940-B8B3C01A-D3CD-40FE-B022-BDD4D1E8E9B1

P31

Q33718940-F6D0A095-359C-46DB-9B86-35C15CE54B7F

P356

Q33718940-1FBF5D63-ED16-4664-A3DF-60BBA80D5788

P433

Q33718940-3D91F325-0AD6-4209-A1C7-97C2802A41B1

P478

Q33718940-DA64332A-A8F7-4CEA-AE8B-D44B17C378FC

P577

Q33718940-7F577183-9E2B-42A0-85F4-708DE66CBADB

P5875

Q33718940-C3895E78-6C97-47D5-B721-2E7062E78BBC

P6179

Q33718940-DA85BFE5-4D1F-4E09-BFF8-31B45C77A7E2

P698

Q33718940-52289CAA-2C50-4FCD-9CFF-078EC2010B7E

P932

Q33718940-58038DF7-E261-4054-BBEF-47260FF0A321

P356

S12072-010-9164-8

P1433

Hepatology international

P1476

Clinicopathological significan ...... on in hepatocellular carcinoma

@en

P2093

Gang Chen

http://www.w3.org/2001/XMLSchema#string

Hongping Yu

http://www.w3.org/2001/XMLSchema#string

Lang Hu

http://www.w3.org/2001/XMLSchema#string

Xiaoqiang Qiu

http://www.w3.org/2001/XMLSchema#string

P2860

Tissue microarrays for high-throughput molecular profiling of tumor specimens

Epigenetic inactivation of a RAS association domain family protein from the lung tumour suppressor locus 3p21.3.

Association of diminished expression of RASSF1A with promoter methylation in primary gastric cancer from patients of central China.

RASSF1A protein expression and correlation with clinicopathological parameters in renal cell carcinoma

Inactivation of RASSF1A, the tumor suppressor gene at 3p21.3 in extrahepatic cholangiocarcinoma

Quantitative evaluation of RASSF1A methylation in the non-lesional, regenerative and neoplastic liver.

Screening for hepatocellular carcinoma in cirrhosis.

Molecular diagnosis of chronic liver disease and hepatocellular carcinoma: the potential of gene expression profiling.

Contribution of DNA and tissue microarray technology to the identification and validation of biomarkers and personalised medicine in breast cancer.

Detection of RASSF1A promoter hypermethylation in serum from gastric and colorectal adenocarcinoma patients.

P2888

s12072-010-9164-8

P304

423-432

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12072-010-9164-8

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P577

2010-01-29T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42372717

http://www.w3.org/2001/XMLSchema#string

P6179

1049465929

http://www.w3.org/2001/XMLSchema#string

P698

20305761

http://www.w3.org/2001/XMLSchema#string

P932

2836437

http://www.w3.org/2001/XMLSchema#string